Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
6.07
+0.22 (3.76%)
At close: Sep 21, 2026, 4:00 PM EDT
6.00
-0.07 (-1.15%)
After-hours: Sep 21, 2026, 7:39 PM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $2.13 billion as of September 21, 2026. Its market cap has increased by 93.38% in one year.
Market Cap
2.13B
Enterprise Value
1.89B
1-Year Change
93.38%
Ranking
Category
Stock Price
$6.07
ChartMarket Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $2.13B, an increase of 1,121.53%. That is a compound annual growth rate of 50.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 2.13B | -30.62% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 2.13B |
| Sarepta Therapeutics | 2.12B |
| UroGen Pharma | 2.11B |
| Biohaven | 2.06B |
| Recursion Pharmaceuticals | 2.05B |
| Zenas BioPharma | 2.05B |
| Kodiak Sciences | 2.05B |
| Vericel | 2.05B |